secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bio Green Med Solution, Inc. (BGMS)
CIK:        0001130166
Form:       8-K
Filed at:   2025-10-07T23:59:59+00:00
Accession:  0001493152-25-017223
Event type: m_and_a
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 2.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio Green Med Solution sells Plogosertib assets to Tethra Biosciences for $300K upfront plus $170K milestone
--------------------------------------------------------------------------------

- Sold all patent rights and IP related to Plogosertib (PLK1 inhibitor) to Tethra Biosciences Inc.
- Total consideration: $300,000 upfront plus a potential $170,000 milestone upon first patient dosing in Phase 2.
- Transaction closed on October 6, 2025, with customary representations and warranties.
- Buyer assumes obligations related to the Compound from closing forward; seller retains excluded liabilities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130166/000149315225017223/0001493152-25-017223-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130166/000149315225017223/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-017223

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer